NEW YORK (GenomeWeb News) – GeneNews this week said that it had closed the first tranche of a private placement offering of its common shares, raising C$1.7 million (US$1.5 million).

The Toronto-based firm issued around 6.8 million common shares at a price of C$.25 per share. It plans to use the proceeds to support continued marketing of its ColonSentry test in Canada, and for pre-launch activities for the test in the US, Europe, and Asia.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The president of France's National Research Agency has resigned, according to Nature News.

A senator wants a "right-to-try" provision in the US Food and Drug Administration funding bill, but an ethicist says at Stat News that it would undermine the role of clinical trials.

In PNAS this week: red algae Porphyra umbicalis genome, deep neural network model for sequencing peptides, and more.

The Guardian's Barbara Ellen has tried out some DNA testing services to see whether they provide valuable information.